‘The Pharmaceutical CRM Outlook: Optimizing returns from operational and analytical investment’ is a report which analyzes the current operational and analytical CRM practises and outlines in detail future developments that will increase the return on investment (ROI) within sales, marketing and customer fulfilment activities. Pharmaceutical companies have invested in new technologies and yet often achieve poor ROI through poor assessment of user needs and customer requirements. Too often, businesses limit the scope of CRM implementation and level of integration within an enterprise and fail to recognise that CRM is as much about changing employee skills and business processes as it is about technology. By investing intelligently in CRM, companies can bring genuine improvement across business functions and reap the rewards of higher ROI. This report looks at the key issues involved in the adoption of CRM within pharmaceutical companies, determines established best practice and provides detailed analysis on key CRM vendors and business applications. The report identifies successful CRM implementations and ROI measurement techniques, which allow pharmaceutical companies to manage their business more effectively.
ISBN 1-84296-412-7
Published: April 2004 - Global. |
